Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation

AJ Kombe Kombe, B Li, A Zahid, HM Mengist… - Frontiers in public …, 2021 - frontiersin.org
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women,
human papillomavirus (HPV) is currently the most common pathogen responsible for female …

HPV self-sampling for cervical cancer screening: a systematic review of values and preferences

H Nishimura, PT Yeh, H Oguntade, CE Kennedy… - BMJ Global …, 2021 - gh.bmj.com
Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as
an additional screening method and HPV DNA testing as an effective approach for the early …

Coupling CRISPR/Cas12a and recombinase polymerase amplification on a stand-alone microfluidics platform for fast and parallel nucleic acid detection

H Zhou, Z Xu, L He, Z Wang, T Zhang, T Hu… - Analytical …, 2023 - ACS Publications
Timely identification of human papillomavirus (HPV) infection is crucial for the prevention of
cervical cancer. Current HPV detection methods mainly rely on polymerase chain reaction …

Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open …

PK Pretsch, LP Spees, NT Brewer… - The Lancet Public …, 2023 - thelancet.com
Background Most cervical cancer in the USA occurs in under-screened women. The My
Body, My Test-3 (MBMT-3) trial sought to assess the efficacy of mailed human …

A framework for cervical cancer elimination in low-and-middle-income countries: a sco** review and roadmap for interventions and research priorities

MB Shin, G Liu, N Mugo, PJ Garcia, DW Rao… - Frontiers in public …, 2021 - frontiersin.org
The World Health Organization announced an ambitious call for cervical cancer elimination
worldwide. With existing prevention and treatment modalities, cervical cancer elimination is …

Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a sco** review of the literature

R Greenley, S Bell, S Rigby, R Legood… - Frontiers in Public …, 2023 - frontiersin.org
Background Cervical cancer is a preventable and inequitably distributed disease. Screening
plays a vital role in prevention, but many women face barriers to participation. The aims of …

Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women …

D Ørnskov, K Jochumsen, PH Steiner, IM Grunnet… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To increase effectiveness of the cervical cancer screening program, self-
sampling can be an option. Both self-collected vaginal samples (SCV) and urine samples …

Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis

D Chu, T Liu, Y Yao - Frontiers in microbiology, 2023 - frontiersin.org
Background Uterine Cervical Carcinoma (UCC) is the most prevalent gynecological
malignancy globally, with a rising incidence in recent years. Accumulating evidence …

Exploring the potential impact of human papillomavirus on infertility and assisted reproductive technology outcomes

L Tramontano, R Sciorio, S Bellaminutti, SC Esteves… - Reproductive …, 2023 - Elsevier
Human papillomavirus (HPV) is a common sexually transmitted disease that has been
linked to both cancer and reproductive health issues. While its impact on fertility and …

Acceptability of self‐taken vaginal HPV sample for cervical screening among an under‐screened Indigenous population

A Adcock, F Cram, B Lawton, S Geller… - Australian and New …, 2019 - Wiley Online Library
Background Human papillomavirus (HPV), the causative agent of cervical cancer, can be
screened for using self‐collected vaginal samples (self‐testing). This may overcome barriers …